Story
Indian Stocks Fall 14% in 2026 as Foreign Investors Exit

Summary
India's benchmark Nifty 50 index has declined nearly 14% year-to-date, pressured by significant foreign capital outflows and elevated valuations. Strong domestic buying has provided a floor for the market, but macroeconomic headwinds persist.
India’s benchmark Nifty 50 index has fallen nearly 14% year-to-date in 2026, as a combination of persistent foreign outflows, high oil prices, and a lack of artificial intelligence catalysts weigh on investor sentiment. The decline has accelerated recently, with the index down 6% over the past month and trading just 1.7% above its 52-week low.
Foreign Outflows and Valuation Concerns
A primary driver of the downturn has been a significant exit of foreign capital. Overseas funds have pulled a net $25 billion from Indian equities so far in 2026, pushing foreign ownership of stocks listed on the National Stock Exchange (NSE) to a 17-year low, according to market data.
Even after the sell-off, valuations remain a concern for international investors. The Nifty 50 trades at approximately 17.6x forward earnings, a 77% premium to the broader MSCI Emerging Markets index. This has made other markets, such as AI-centric Taiwan and South Korea, more attractive destinations for global capital this year.
Macroeconomic pressures have further compounded the issue. As a net importer of about 80% of its oil, India's economy is strained by rising energy costs. This, coupled with geopolitical tensions, has pushed the Indian rupee to record lows against the U.S. dollar, eroding returns for foreign investors.
Domestic Buying Provides a Buffer
Despite the heavy foreign selling, the market has been supported by robust domestic investment. Local investors have purchased a net $60 billion in Indian stocks this year, more than doubling the amount of foreign outflows and preventing a more severe market crash.
AdCorporate fundamentals have also shown resilience. According to a note from Abakkus, first-quarter corporate earnings broadly beat expectations, supported by strong consumer demand. Major investment banks also maintain optimistic long-term targets, though their calls came before the most recent market decline. A July report from Morgan Stanley set a base case target of 89,000 for the BSE Sensex by June 2027, while Goldman Sachs held a target of 26,500 for the Nifty 50.
Outlook: A Market in Re-rating
The Indian market appears to be caught between two powerful, opposing forces, creating a state of re-rating rather than a clear downtrend or a bargain opportunity. For a more decisive recovery, analysts point to three necessary conditions that are not yet in place:
- A significant narrowing of the valuation premium over other emerging markets.
- A sustained reversal of foreign capital outflows into positive territory.
- Stabilization in oil prices and the Indian rupee.
Until these factors shift, the market may lack a clear catalyst for a sustained rebound. Goldman Sachs has previously noted that large-cap banks are likely to be primary beneficiaries if and when foreign capital begins to return to the Indian market.
Read next
More on Stocks
Hewlett Packard Enterprise Secures $1.2 Billion AI Infrastructure Order
Hewlett Packard Enterprise has received a $1.2 billion order for its AI server systems from a major U.S. cloud provider, boosting its stock and validating its growing AI infrastructure business.

Toho Stock Swings After PHC Confirms ¥200 Billion Takeover Proposal
Shares of Toho initially fell over 4% before reversing course after biomedical firm PHC Holdings confirmed it had received a non-binding takeover bid reportedly worth ¥200 billion from the entertainment giant.

Japan's Nikkei Surges on Chip Stock Rally; Softer US Inflation Boosts Asian Markets
Asian stocks advanced, led by a 2.5% jump in Japan's Nikkei 225, after a strong forecast from Micron Technology boosted chipmakers. Softer-than-expected U.S. inflation data also eased concerns about further Federal Reserve rate hikes.

PHC Holdings Stock Surges to 3-Year High on Toho Acquisition Offer
Shares in the Japanese healthcare device maker jumped nearly 13% after the company confirmed it had received a non-binding takeover proposal from pharmaceutical firm Toho Holdings.